医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

CartiHeal Granted Four Patents Covering Agili-C™ Cartilage Regeneration Technology

2014年09月03日 PM08:00
このエントリーをはてなブックマークに追加


 

KFAR SABA, Israel

CartiHeal (2009) Ltd., a privately held medical device company headquartered in Kfar Saba, Israel, announces the issuance of four patents — three in the U.S. and one in Japan — for its proprietary cell-free, off-the-shelf cartilage regeneration technology for patients with injuries to the articular surface of joints.

The three U.S. patents nos. 8,808,725, 8,790,681 and 8,802,115, and the Japanese patent 5536793, describe the use of modified coral scaffolds for the treatment of cartilage and bone defects. These patents cover a wide range of claims including treatment of cartilage and osteochondral defects, osteoarthritis and a variety of joint disorders. The patents relate to the Agili-C™ implant, a bi-phasic, coralline-hyaluronate composite scaffold which has undergone chemical, physical and biological modifications. The implant demonstrated clinical safety and effectiveness in a series of clinical trials, by enhancing regeneration of true hyaline cartilage and subchondral bone.

“These four patents strengthen CartiHeal’s IP portfolio, and position the company at the forefront of innovative technologies in the field of cartilage regeneration,” reports Nir Altschuler, founder and CEO of CartiHeal. “Cartilage regeneration represents one of medicine’s most challenging unmet needs. We are proud to say that CartiHeal and its breakthrough technology are able to meet this challenge.”

About CartiHeal

CartiHeal (2009) Ltd., a privately held medical device company headquartered in Israel, is a pioneer in the field of regenerative medicine. CartiHeal’s CE-marked Agili-C™ implant has shown to promote regeneration of true hyaline cartilage and its subchondral bone, simultaneously without the use of cells, growth factors or other exogenous agents. Agili-C™ represents a significant medical breakthrough and was voted one of the top 10 most exciting Israeli medical-device and pharmaceutical developments to watch for in 2014.

For more information about the company please visit: www.cartiheal.com

CONTACT

CartiHeal
Caty Pearl, +972-54-8081020
Marketing Manager
catyp@pearlcom.co.il

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Takeda to Highlight Broad Oncology Portfolio and Pipeline Data at the American Society of Clinical Oncology (ASCO) and the Congress of the European Hematology Association (EHA) Annual Meetings
  • Cerveau Technologies, Inc.与日本东京都老人综合研究所签订研究协议
  • 继美国和英国之后,中国向Personalis, Inc.签发ACE©技术专利,扩大了其在国际上的知名度
  • セルヴォー・テクノロジーズが日本の東京都健康長寿医療センター研究所と研究契約を締結
  • 国際的な食品・飲料企業の連合が、世界の供給食料から人工トランス脂肪酸を排除するための世界保健機関とResolve to Save Livesによる呼び掛けを支持